Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanolattix is a biotechnology company specializing in advanced organoid technology for drug discovery and regenerative medicine. The company utilizes a proprietary 3D micro-lattice scaffolding platform to create highly standardized and physiologically relevant human organoid models. These models are used for high-throughput drug screening, toxicity testing, and personalized medicine applications. Nanolattix aims to bridge the gap between traditional cell cultures and clinical trials by providing more accurate predictive models for pharmaceutical development. Their technology supports the growth of various tissue types, including liver, lung, and intestinal organoids, which are provided as services to pharmaceutical firms to optimize lead selection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanolattix Health Technology.